OA10286A - Inhibiting photodecomposition of 3-substituted-2-oxindoles - Google Patents

Inhibiting photodecomposition of 3-substituted-2-oxindoles Download PDF

Info

Publication number
OA10286A
OA10286A OA60821A OA60821A OA10286A OA 10286 A OA10286 A OA 10286A OA 60821 A OA60821 A OA 60821A OA 60821 A OA60821 A OA 60821A OA 10286 A OA10286 A OA 10286A
Authority
OA
OAPI
Prior art keywords
red
yellow
light
lake
dye
Prior art date
Application number
OA60821A
Other languages
English (en)
Inventor
Newlin Williard C Jr
Sharon M Laughlin
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of OA10286A publication Critical patent/OA10286A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4883—Capsule finishing, e.g. dyeing, aromatising, polishing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Polymerisation Methods In General (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
OA60821A 1995-04-24 1996-04-24 Inhibiting photodecomposition of 3-substituted-2-oxindoles OA10286A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1995/000287 WO1996033701A1 (en) 1995-04-24 1995-04-24 Inhibiting photodecomposition of 3-substituted-2-oxindoles

Publications (1)

Publication Number Publication Date
OA10286A true OA10286A (en) 1997-09-19

Family

ID=36997502

Family Applications (1)

Application Number Title Priority Date Filing Date
OA60821A OA10286A (en) 1995-04-24 1996-04-24 Inhibiting photodecomposition of 3-substituted-2-oxindoles

Country Status (30)

Country Link
EP (1) EP0827399A1 (is)
JP (1) JPH10506635A (is)
KR (1) KR100189585B1 (is)
CN (1) CN1053667C (is)
AP (1) AP607A (is)
AR (1) AR002728A1 (is)
AU (1) AU692378B2 (is)
BG (1) BG100531A (is)
BR (1) BR9602024A (is)
CO (1) CO4700418A1 (is)
FI (1) FI973988A0 (is)
HR (1) HRP960194A2 (is)
HU (1) HU216544B (is)
IL (1) IL117969A0 (is)
IS (1) IS4339A (is)
MA (1) MA23848A1 (is)
NO (1) NO961622L (is)
NZ (1) NZ286432A (is)
OA (1) OA10286A (is)
PE (1) PE34397A1 (is)
RO (1) RO113305B1 (is)
RU (1) RU2109510C1 (is)
SG (1) SG64924A1 (is)
SI (1) SI9600133A (is)
SK (1) SK51296A3 (is)
TR (1) TR199600300A2 (is)
UA (1) UA42739C2 (is)
WO (1) WO1996033701A1 (is)
YU (1) YU25096A (is)
ZA (1) ZA963210B (is)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111526730B (zh) 2017-12-29 2024-02-23 卡夫食品集团品牌有限责任公司 使用天然稳定剂改善的水包油乳液的氧化稳定性

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3136282A1 (de) * 1981-09-12 1983-03-24 Hoechst Ag "verfahren zur stabilisierung photoinstabiler arzneistoffe sowie stabilisierte arzneizubereitungen"
HUT59592A (en) * 1990-07-20 1992-06-29 Egyt Gyogyszervegyeszeti Gyar Process for the preparation of solid medical products
TW438798B (en) * 1992-10-07 2001-06-07 Pfizer 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions

Also Published As

Publication number Publication date
IS4339A (is) 1996-10-25
EP0827399A1 (en) 1998-03-11
HUP9601057A2 (en) 1997-04-28
TR199600300A2 (tr) 1996-11-21
RO113305B1 (ro) 1998-06-30
HU9601057D0 (en) 1996-06-28
NO961622D0 (no) 1996-04-23
NO961622L (no) 1996-10-25
KR100189585B1 (ko) 1999-06-01
AP607A (en) 1997-08-27
FI973988A7 (fi) 1997-10-17
JPH10506635A (ja) 1998-06-30
ZA963210B (en) 1997-10-23
RU2109510C1 (ru) 1998-04-27
CO4700418A1 (es) 1998-12-29
SG64924A1 (en) 1999-05-25
BG100531A (bg) 1997-06-30
WO1996033701A1 (en) 1996-10-31
AP9600787A0 (en) 1996-04-30
UA42739C2 (uk) 2001-11-15
HUP9601057A3 (en) 1997-05-28
HRP960194A2 (en) 1998-02-28
SI9600133A (en) 1996-10-31
BR9602024A (pt) 1998-10-06
KR960037656A (ko) 1996-11-19
NZ286432A (en) 1998-05-27
AU692378B2 (en) 1998-06-04
CN1139110A (zh) 1997-01-01
CN1053667C (zh) 2000-06-21
FI973988L (fi) 1997-10-17
AU5085196A (en) 1996-11-07
SK51296A3 (en) 1997-04-09
IL117969A0 (en) 1996-08-04
AR002728A1 (es) 1998-04-29
FI973988A0 (fi) 1997-10-17
HU216544B (hu) 1999-07-28
PE34397A1 (es) 1997-09-29
MA23848A1 (fr) 1996-12-31
YU25096A (sh) 1998-08-14

Similar Documents

Publication Publication Date Title
US5331000A (en) Antipyretic and analgesic methods and compositions containing optically pure R(-) ketoprofen
KR950703539A (ko) 당뇨병 합병증 치료용 치환된 피리미딘(substituted pyrimidines for control or diabetic complications)
DE59209706D1 (de) S(+)-Ibuprofen enthaltende Arzneimittel
KR910004600A (ko) 류코트리엔의 생합성 억제제로서의 (퀴놀린-2-일메톡시)인돌
FR2684876A1 (fr) Compositions pharmaceutiques stabilisees comprenant un compose inhibiteur de la hmg-coa reductase et procede pour leur preparation.
RS49504B (sr) Antitrombični i antiaterogeni farmaceutski preparat koji obuhvata derivat tienopiridina i inhibitor hmg-coa-reduktaze
JO2239B1 (en) Method for preparing benzothophen derivatives
PL181215B1 (pl) Kompozycja farmaceutyczna zawierająca ibuprofen i kodeinę oraz sposób jej wytwarzania
CA2003478A1 (en) Combination of an hmg coa reductase inhibitor and other type of serum cholesterol reducing agent and method for lowering serum cholesterol using such combination
CA1069441A (en) Pharmaceutical composition containing 2,1,3-benzothiazole
OA10286A (en) Inhibiting photodecomposition of 3-substituted-2-oxindoles
CA2217513C (en) Pharmaceutical agents for the treatment of alzheimer's disease
US3519717A (en) Novel method for lowering high blood pressure and compositions therefor
CA2216931A1 (en) Inhibiting photodecomposition of 3-substituted-2-oxindoles
US4188393A (en) Treating spastic conditions or relaxing muscles
EP0444546B1 (en) Hydantoin derivatives for use as hypoglycemic and/or hypolipidemic agents
US3592905A (en) Therapeutic methods
NL193821C (nl) Farmaceutisch preparaat.
US4145421A (en) Treating spastic conditions
WO1999061016A1 (fr) Inhibiteurs de cyclo-oxygenase-2
US4329354A (en) Thiazoline and imidazoline derivatives useful as antidepressants
AU620658B2 (en) Memory-enhancing compositions containing dioxopiperidine derivatives
BE881717A (fr) Medicament a base d'un compose heterocyclique bicyclique condense
RU96108120A (ru) Способ ингибирования, таблетка и капсула
TH13801A (th) สารผสมทางเภสัชกรรมที่เสถียรซึ่งประกอบด้วยสารยับยั้ง HMG-CoA รีดักเตส